TRITAC Trademark

Trademark Overview

On Thursday, December 15, 2016, a trademark application was filed for TRITAC with the United States Patent and Trademark Office. The USPTO has given the TRITAC trademark a serial number of 87270473. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2019. This trademark is owned by Harpoon Therapeutics, Inc.. The TRITAC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors

Pharmaceutical research and development
tritac

General Information

Serial Number87270473
Word MarkTRITAC
Filing DateThursday, December 15, 2016
Status700 - REGISTERED
Status DateTuesday, June 25, 2019
Registration Number5788225
Registration DateTuesday, June 25, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors
Goods and ServicesPharmaceutical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 21, 2016
Primary Code005
First Use Anywhere DateMonday, July 30, 2018
First Use In Commerce DateMonday, July 30, 2018
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 21, 2016
Primary Code042
First Use Anywhere DateMonday, July 30, 2018
First Use In Commerce DateMonday, July 30, 2018

Trademark Owner History

Party NameHarpoon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameHarpoon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameHarpoon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Trademark Events

Event DateEvent Description
Monday, August 21, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 19, 2016NEW APPLICATION ENTERED
Wednesday, December 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 16, 2017ASSIGNED TO EXAMINER
Tuesday, March 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 2, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 2, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 24, 2018TEAS STATEMENT OF USE RECEIVED
Monday, August 21, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 13, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2017SOU EXTENSION 1 FILED
Wednesday, December 13, 2017SOU EXTENSION 1 GRANTED
Friday, December 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 12, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, June 12, 2018SOU EXTENSION 2 FILED
Tuesday, June 12, 2018SOU EXTENSION 2 GRANTED
Thursday, June 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 31, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 24, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, October 24, 2018SOU EXTENSION 3 FILED
Friday, November 2, 2018SOU EXTENSION 3 GRANTED
Wednesday, October 24, 2018USE AMENDMENT FILED
Friday, November 2, 2018STATEMENT OF USE PROCESSING COMPLETE
Saturday, November 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 27, 2018SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 27, 2018NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 21, 2019ASSIGNED TO LIE
Wednesday, May 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 22, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 23, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 25, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, April 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 25, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

tritac pharmaceutical cancer treatment preparations tumors products biological development research immunotherapy